257 related articles for article (PubMed ID: 10535040)
1. [Hyperhomocysteinemia, a risk factor for atherosclerosis: causes and effects].
Weiss N; Pietrzik K; Keller C
Dtsch Med Wochenschr; 1999 Sep; 124(38):1107-13. PubMed ID: 10535040
[No Abstract] [Full Text] [Related]
2. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
3. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
4. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
Boers GH
Semin Thromb Hemost; 2000; 26(3):291-5. PubMed ID: 11011846
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine--relevant for atherogenesis?
Kircher T; Sinzinger H
Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
[TBL] [Abstract][Full Text] [Related]
6. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
7. [The role of hyper-homocysteinemia in the etiology of some vascular diseases].
Czeizel E; Matos L
Orv Hetil; 1998 Sep; 139(37):2191-6. PubMed ID: 9769688
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
10. [Homocysteinemia and vascular disease--a new risk factor is born].
Reis RP; Luís AS
Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
[TBL] [Abstract][Full Text] [Related]
12. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
Asfar S; Safar HA
J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
[TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and the heart.
Turner SL; Bechtel GA
Adv Nurse Pract; 1999 Mar; 7(3):71-3. PubMed ID: 10373803
[No Abstract] [Full Text] [Related]
17. Hyperhomocysteinemia and risk of vascular disease in women.
Verhoef P
Semin Thromb Hemost; 2000; 26(3):325-34. PubMed ID: 11011850
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine: evidence for a causal relationship with cardiovascular disease.
Scott CH; Sutton MS
Cardiol Rev; 1999; 7(2):101-7. PubMed ID: 10348972
[TBL] [Abstract][Full Text] [Related]
19. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
20. [Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].
Falcón CR; Carreras LO
Sangre (Barc); 1998 Feb; 43(1):47-54. PubMed ID: 9577181
[No Abstract] [Full Text] [Related]
[Next] [New Search]